Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The FDA rolled out a smartphone app March 22 to provide information about prescription and over-the-counter drugs.
The FDA on March 20 approved Seattle Genetics' drug Adcetris to treat advanced forms of Hodgkin lymphoma in combination with chemotherapy.
Genentech earned FDA approval for a new method of administering its 0.3 milligram eye drug Lucentis March 21.
California issued a cease-and-desist order to Pharmedium Services, a compounding business owned by wholesaler AmerisourceBergen, according to STAT.
Johnson & Johnson Executive Vice President and CFO Dominic Caruso will retire from his 19-year stint at the company in September, at which point Joseph Wolk, vice president of investor relations, will take over, CNBC reports.
Amazon is shifting costs onto suppliers and reducing the amount of small, inexpensive items consumers can buy off its site, unnamed sources told Bloomberg.
CVS Health selected former Eli Lilly CFO Derica Rice to serve as the president of its pharmacy benefit management division, CVS Caremark, according to The Wall Street Journal.
The list prices for nearly two dozen drugs increased by at least 200 percent since January 2017, according to an analysis by Pharmacy Benefits Consultants.
Walgreens Boots Alliance will pay Massachusetts $5.5 million to resolve allegations it overcharged prescription drugs covered by the state workers' compensation insurance program.
Improving data-driven decision making is the area supply chain leaders deemed most critical to the future of supply chain in healthcare, according to a survey of the Best 50 provider organizations conducted by the Global Healthcare Exchange.